A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna and EU amend COVID-19 vaccine agreement to allow Spikevax deliveries scheduled for July, August to be delivered later in the year to allow EU members to receive Omicron-specific vaccines; EU to buy an additional 15 million vaccine doses
Published: August 10, 2022 by SeeNews Pharmaceuticals
Moderna reports Q2 net income down 21% from a year ago to US$2.2B, with total revenue up 9% to US$4.75B; Spikevax COVID-19 vaccine sales hit US$4.53B, operating expenses grow 78% to US$2.3B, company records US$499.0M in inventory write-downs
Published: August 04, 2022 by Associated Press
US HHS warns that purchase of up to 171 million doses of bivalent COVID-19 booster doses from Pfizer, Moderna is not enough to treat entire US population; option to buy additional 600 million doses will need additional funding from Congress
Published: August 02, 2022 by FiercePharma
FDA approves emergency use authorization for Moderna and Pfizer-BioNTech COVID-19 vaccines for children as young as six months old; Moderna vaccine administered in two doses, Pfizer vaccine administered in three doses
Published: August 02, 2022 by US Official News
US buys 66 million doses of Moderna’s mRNA-1273.222 bivalent COVID-19 booster candidate for US$1.74B, with option to buy 234 million more doses; Moderna has developed two bivalent candidates based on different COVID-19 strains
Published: August 01, 2022 by Accesswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count